Search Results - "ALLEZ, M."

Long‐term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience by Wils, P., Bouhnik, Y., Michetti, P., Flourie, B., Brixi, H., Bourrier, A., Allez, M., Duclos, B., Serrero, M., Buisson, A., Amiot, A., Fumery, M., Roblin, X., Peyrin‐Biroulet, L., Filippi, J., Bouguen, G., Abitbol, V., Coffin, B., Simon, M., Laharie, D., Pariente, B.

“…Summary Background Long‐term outcome of ustekinumab in Crohn's disease (CD) has not been evaluated. Aim To evaluate the long‐term efficacy and safety of…”
Get full text

Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation by Snowden, J A, Saccardi, R, Allez, M, Ardizzone, S, Arnold, R, Cervera, R, Denton, C, Hawkey, C, Labopin, M, Mancardi, G, Martin, R, Moore, J J, Passweg, J, Peters, C, Rabusin, M, Rovira, M, van Laar, J M, Farge, D

“…In 1997, the first consensus guidelines for haematopoietic SCT (HSCT) in autoimmune diseases (ADs) were published, while an international coordinated clinical…”
Get full text

Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery by Mondot, S, Lepage, P, Seksik, P, Allez, M, Tréton, X, Bouhnik, Y, Colombel, J F, Leclerc, M, Pochart, P, Doré, J, Marteau, P

“…Preventing postoperative recurrence after ileocolonic resection (ICR) for Crohn's disease (CD) is challenging. Defining the disturbances of the microbial…”
Get more information

Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study by Denis, B, Lafaurie, M, Donay, J.-L, Fontaine, J.-P, Oksenhendler, E, Raffoux, E, Hennequin, C, Allez, M, Socie, G, Maziers, N, Porcher, R, Molina, J.-M

“…Graphical abstract…”
Get full text

Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease by Feagan, B. G., Sandborn, W. J., D'Haens, G., Lee, S. D., Allez, M., Fedorak, R. N., Seidler, U., Vermeire, S., Lawrance, I. C., Maroney, A. C., Jurgensen, C. H., Heath, A., Chang, D. J.

“…Summary Background Many patients with active Crohn's disease do not adequately respond to therapies, highlighting the need for new treatments. Aims To conduct…”
Get full text

Review article: anti TNF‐α induced psoriasis in patients with inflammatory bowel disease by FIORINO, G., ALLEZ, M., MALESCI, A., DANESE, S.

“…Summary Background  Anti TNF‐α agents are used successfully for several autoimmune diseases, including IBD and psoriasis. An emerging challenge is the…”
Get full text

The surgical intervention: Earlier or never? by Bemelman, W.A., PhD, Allez, M., MD, PhD

“…Abstract Crohn's disease (CD) is a chronic and progressive disease characterized by the presence of inflammation in different segments of the digestive tract,…”
Get full text

CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease by Barnich, Nicolas, Carvalho, Frédéric A, Glasser, Anne-Lise, Darcha, Claude, Jantscheff, Peter, Allez, Matthieu, Peeters, Harald, Bommelaer, Gilles, Desreumaux, Pierre, Colombel, Jean-Frédéric, Darfeuille-Michaud, Arlette

“…The ileal mucosa of Crohn disease (CD) patients is abnormally colonized by adherent-invasive E. coli (AIEC) that are able to adhere to and invade intestinal…”
Get full text

Factors associated with pregnancy outcome in anti‐TNF treated women with inflammatory bowel disease by Seirafi, M., Vroey, B., Amiot, A., Seksik, P., Roblin, X., Allez, M., Peyrin‐Biroulet, L., Marteau, P., Cadiot, G., Laharie, D., Boureille, A., De Vos, M., Savoye, G., Rahier, J.‐F., Carbonnel, F., Bonaz, B., Colombel, J.‐F., Bouhnik, Y.

“…Summary Background The safety of anti‐tumour necrosis factor (TNF) agents during pregnancy is a major concern for child‐bearing women and physicians. Aim To…”
Get full text

Prognosis and molecular characteristics of IBD-associated colorectal cancer: Experience from a French tertiary-care center by Hammoudi, N., Lehmann-Che, J., Lambert, J., Amoyel, M., Maggiori, L., Salfati, D., Tran Minh, M.L., Baudry, C., Asesio, N., Poirot, B., Lourenco, N., Corte, H., Allez, M., Aparicio, T., Gornet, J.M.

“…Little is known about the prognosis of colorectal cancer associated with inflammatory bowel disease (CRC-IBD) in a real-world cohort in France. We conducted a…”
Get full text

Regulatory T cells. Peace keepers in the gut by Allez, Matthieu, Mayer, Lloyd

“…The mucosa‐associated lymphoid tissue (MALT) has the task of protecting the host from pathogens while maintaining the integrity of the gut. Immune responses…”
Get full text

The efficacy and safety of a third anti‐TNF monoclonal antibody in Crohn’s disease after failure of two other anti‐TNF antibodies by ALLEZ, M., VERMEIRE, S., MOZZICONACCI, N., MICHETTI, P., LAHARIE, D., LOUIS, E., BIGARD, M.‐A., HÉBUTERNE, X., TRETON, X., KOHN, A., MARTEAU, P., CORTOT, A., NICHITA, C., VAN ASSCHE, G., RUTGEERTS, P., LÉMANN, M., COLOMBEL, J.‐F.

“…Summary Background  Adalimumab (ADA) and certolizumab pegol (CZP) have demonstrated efficacy in Crohn’s disease (CD) patients previously treated with…”
Get full text

Pneumocystis jirovecii Pneumonia in Patients with Inflammatory Bowel Disease–a Case Series by Vieujean, Sophie, Moens, Annick, Hassid, Deborah, Rothfuss, Katja, Savarino, Edoardo Vincenzo, Vavricka, Stephan R, Reenaers, Catherine, Jacobsen, Bent Ascanius, Allez, Matthieu, Ferrante, Marc, Rahier, Jean-Francois

“…Abstract Background and Aim Pneumocystis jirovecii pneumonia [PJP] is a very rare, potentially life-threatening pulmonary fungal infection that occurs in…”
Get full text

Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium by Rup, B., Pallardy, M., Sikkema, D., Albert, T., Allez, M., Broet, P., Carini, C., Creeke, P., Davidson, J., De Vries, N., Finco, D., Fogdell‐Hahn, A., Havrdova, E., Hincelin‐Mery, A., C. Holland, M., H. Jensen, P. E., Jury, E. C., Kirby, H., Kramer, D., Lacroix‐Desmazes, S., Legrand, J., Maggi, E., Maillère, B., Mariette, X., Mauri, C., Mikol, V., Mulleman, D., Oldenburg, J., Paintaud, G., R. Pedersen, C., Ruperto, N., Seitz, R., Spindeldreher, S., Deisenhammer, F.

“…Summary Biopharmaceuticals (BPs) represent a rapidly growing class of approved and investigational drug therapies that is contributing significantly to…”
Get full text

Successive Treatment With Cyclosporine and Infliximab in Steroid-Refractory Ulcerative Colitis by Leblanc, S, Allez, M, Seksik, P, Flourié, B, Peeters, H, Dupas, J L, Bouguen, G, Peyrin-Biroulet, L, Duclos, B, Bourreille, A, Dewit, O, Bouhnik, Y, Michetti, P, Chaussade, S, Saussure, P, Mary, J Y, Colombel, J F, Lémann, M

“…Rescue therapy with either cyclosporine (CYS) or infliximab (IFX) is an effective option in patients with intravenous steroid-refractory attacks of ulcerative…”
Get full text

The outcome of infliximab dose doubling in 157 patients with ulcerative colitis after loss of response to infliximab by Dumitrescu, G., Amiot, A., Seksik, P., Baudry, C., Stefanescu, C., Gagniere, C., Allez, M., Cosnes, J., Bouhnik, Y.

“…Summary Background Optimising infliximab therapy is recommended in inflammatory bowel disease (IBD) patients who lose response to infliximab; however, there…”
Get full text

French protocol for the diagnosis and management of hematopoietic stem cell transplantation in autoimmune diseases by Farge, D., Pugnet, G., Allez, M., Castilla-Llorente, C., Chatelus, E., Cintas, P., Faucher-Barbey, C., Labauge, P., Labeyrie, C., Lioure, B., Maria, A., Michonneau, D., Puyade, M., Talouarn, M., Terriou, L., Treton, X., Wojtasik, G., Zephir, H., Marjanovic, Z.

“…Hematopoietic stem cell transplantation (HSCT) for severe ADs was developed over the past 25years and is now validated by national and international medical…”
Get full text

National diagnostic and care protocols (NDCP) for hematopoietic stem cell transplantation in autoimmune diseases by Farge, D, Pugnet, G, Allez, M, Castilla-Llorente, C, Chatelus, E, Cintas, P, Faucher-Barbey, C, Labauge, P, Labeyrie, C, Lioure, B, Maria, A, Michonneau, D, Puyade, M, Talouarn, M, Terriou, L, Treton, X, Wojtasik, G, Zephir, H, Marjanovic, Z

“…Hematopoietic stem cell transplantation (HSCT) for severe ADs was developed over the past 25years and is now validated by national and international medical…”
Get full text

Prognosis of Lymphoma in Patients With Known Inflammatory Bowel Disease: A French Multicentre Cohort Study by Severyns, T, Kirchgesner, J, Lambert, J, Thieblemont, C, Amiot, A, Abitbol, V, Treton, X, Cazals-Hatem, D, Malamut, G, Coppo, P, Galicier, L, Walter-Petrich, A, Deau-Fischer, B, Besson, C, Aparicio, T, Beaugerie, L, Allez, M, Gornet, J M

“…Abstract Background and Aims The prognosis of lymphoma that occurs in patients with inflammatory bowel disease [IBD] is poorly known. Methods A multicentre…”
Get full text

Early intervention in psoriasis and immune-mediated inflammatory diseases: A hypothesis paper by Girolomoni, G., Griffiths, C. E. M., Krueger, J., Nestle, F. O., Nicolas, J-F., Prinz, J. C., Puig, L., Ståhle, M., van de Kerkhof, P. C. M., Allez, M., Emery, P., Paul, C.

“…Abstract Psoriasis is an immune-mediated inflammatory disease (IMID) which may have a major impact on a patient's life, especially when the disease is moderate…”
Get full text